retatrutide approval Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide FDA Approval Status 2026:

Most telehealth clinics offer free initial consultations with their weight-loss programs as well as free lab work and home delivery of medication

Retatrutide posted 24% body weight loss in Phase 2 by targeting three receptors instead of one

Semaglutide works by mimicking the GLP-1 hormone, which helps regulate appetite and slows gastric emptying, promoting feelings of fullness for longer periods

Retatrutide vs Tirzepatide: Triple vs Dual Receptor Research Explained Retatrutide and Tirzepatide are two of the most searched compounds in modern incretin-based research

Paying for a plan is not the same as receiving a prescription

Instead, it connects patients with a network of licensed clinicians who handle all medical evaluations, prescribing decisions, and ongoing care